Delivery Order SPE2DX22D0010-SPE2D826FCX43
- Not listed
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $8,325.01 on January 23, 2026, for the supply of MS Contin Tablets 60mg. The award was made by the Medical Supply Chain division of the Defense Logistics Agency without a set-aside designation, with performance scheduled for completion by January 26, 2026, at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under the parent company's...
- AmerisourceBergen Drug Corp was awarded a delivery order on October 16, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of MS Contin Tablets 30mg, a controlled-release morphine sulfate pain management pharmaceutical. This non-competitive delivery order, valued at $2,706.81 with firm fixed pricing, is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of MS Contin Tabs 30mg, a morphine sulfate pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $8.6K and is scheduled for completion by September 10, 2025. The contract is not set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.36 to AmerisourceBergen Drug Corp for 100 tablets of MS Contin ER 15 mg, a controlled-release morphine sulfate pain management medication. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 18, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $5,497.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of MS Continuous Release Tablets 30mg, with an ultimate completion date of July 31, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $10,618.14 delivery order by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award through full and open competition. This delivery order operates as a child contract under...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,504.60 by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026. This firm fixed-price delivery order, which carries an ultimate completion date of February 3, 2026, represents a child contract under a larger indefinite delivery vehicle. The award is non-set-aside and was competitively awarded, reflecting the contractor's...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $10,447.93 on January 19, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 20, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting the contractor's capability to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $135,070.25 to AmerisourceBergen Drug Corp on August 16, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a delivery order valued at $14,800.80 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCX43Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $10,590.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of MS Continuation Tablets 30mg on February 3, 2026, with an ultimate completion date of February 4, 2026. This competitive award, placed to the prime contractor's Corporate Office located in Conshohocken, Pennsylvania, represents a child contract under a larger indefinite delivery contract vehicle. The delivery order was issued with no set-aside designation, indicating full and open competition among qualified pharmaceutical suppliers. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with both brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 2/2/26 |